What is Teriparatide?
A parathyroid hormone fragment, PTH(1-34), with human trials and approved-pen labeling; the research vial is not the approved pen.
Teriparatide in the library · Healing & Repair Peptides · Human Trials · What are peptides?
153 registered trials · 421 indexed papers · 1764 human / 295 animal studies
From the PeptideWhiz library entry. "As described" sections summarize claims made in the sources; they are not PeptideWhiz endorsements.
What it is
Teriparatide is described as rhPTH(1-34), with human trials and approved labeling behind it. The research-vial calculation is described as not interchangeable with the approved teriparatide pen, and pen handling instructions are formulation-specific.
Research context (as described)
- The research context includes the DATA and DATA-Switch trials examining combined and sequenced teriparatide and denosumab therapy (Leder et al., 2014, PMID 24517156; Leder et al., 2015, PMID 26144908), and the Endocrine Society and AACE guidelines on postmenopausal osteoporosis (Eastell et al., 2019, PMID 30907953; Camacho et al., 2020, PMID 32427503).
Registered human trials (153)
Peer-reviewed studies (421)
More cited research
- Real-world evidence indicates romosozumab use is associated with a greater reduction in osteoporotic fractures than PTH (1-34) analogs in women (2026, human observational)
- A biomimetic and bioactive scaffold with intelligently pulsatile teriparatide delivery for local and systemic osteoporosis regeneration (2023, human observational)
- Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claim (2022, human observational)
- Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling (2021, human trial (non-randomized))
- Abaloparatide is more potent than teriparatide in restoring bone mass and strength in type 1 diabetic male mice (2024, animal)
- Abaloparatide and teriparatide enhance mandibular growth in adolescent rats with site-specific and mechano-related effects (2023, animal)
- Abaloparatide outperforms teriparatide in protecting against alveolar bone loss in experimental periodontitis (2023, animal)
- An injectable liposome-anchored teriparatide incorporated gallic acid-grafted gelatin hydrogel for osteoarthritis treatment (2023, animal)
Conditions researched
- Anemia
- Anti-aging & longevity
- Endometriosis
- Gum disease (periodontal) & oral health
- Hyperparathyroidism
- Immune system (general)
- Insulin resistance, prediabetes & type 2 diabetes
- Kidney protection (CKD, diabetic kidney, lupus kidney)
- Menopause & perimenopause
- Osteoarthritis, cartilage loss & avoiding joint replacement
- Osteoporosis and bone density
- Post-surgical inflammation and surgery recovery
- Pregnancy and breastfeeding: safety notes
- Rheumatoid arthritis
- Skin, hair loss, wounds & mast-cell/histamine reactivity
Related compounds
- Parathyroid Hormone (PTH 1-84)
- Calcitonin
- Cyanocobalamin (Vitamin B12)
- Methylene blue (non-peptide stack partner)
- ACTH (Corticotropin)
- Glutathione
- IGF-1 LR3
- Oxytocin
- BNP (Nesiritide)
- Leuprolide
FAQ
What is Teriparatide?
A parathyroid hormone fragment, PTH(1-34), with human trials and approved-pen labeling; the research vial is not the approved pen.
How many registered human trials study Teriparatide?
The PeptideWhiz trial index lists 153 registered trials for Teriparatide, the most recent from 2027.
How much published research exists on Teriparatide?
The PeptideWhiz paper index links 421 PubMed papers to Teriparatide; by study type, 1764 human and 295 animal studies.
Which conditions is Teriparatide researched for?
Anemia, Anti-aging & longevity, Endometriosis, Gum disease (periodontal) & oral health, Hyperparathyroidism, Immune system (general), Insulin resistance, prediabetes & type 2 diabetes, Kidney protection (CKD, diabetic kidney, lupus kidney), Menopause & perimenopause, Osteoarthritis, cartilage loss & avoiding joint replacement, Osteoporosis and bone density, Post-surgical inflammation and surgery recovery, Pregnancy and breastfeeding: safety notes, Rheumatoid arthritis, Skin, hair loss, wounds & mast-cell/histamine reactivity.
Research and education only. Not medical advice. No dosing guidance. Data: ClinicalTrials.gov registry and PubMed via the PeptideWhiz index (204,289 studies).